Cardiac troponin in patients hospitalized with acute decompensated heart failure: A systematic review and meta-analysis

Journal of Hospital Medicine

Volumn 11, Issue 6, 2016, Pages 446-454

  Yousufuddin, Mohammed ^a   Abdalrhim, Ahmed D ^a   Wang, Zhen ^a   Murad, M Hassan ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE HEART FAILURE; FOLLOW UP; HOSPITAL MORTALITY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; ACUTE DISEASE; BLOOD; HEART FAILURE; META ANALYSIS; RISK FACTOR;

ACUTE DISEASE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; PATIENT READMISSION; RISK FACTORS; TROPONIN;

EID: 84975735268     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.2558     Document Type: Review

References (54)

1. Centers for Medicare & Medicaid Services. 30-day unplanned readmission and death measures. Medicare website. Available at: http://www.medicare.gov/hospitalcompare/Data/30-day-measures.html. accessed July 3, 2015.
2. Nagarajan V, Hernandez AV, Tang WHW. Prognostic value of cardiac troponin in chronic stable hear failure: A systematic review. Heart. 2012;98:1778-1786.
3. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA. 2000;283:2008-2012.
4. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
5. Stang A. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-605.
6. Felker GM, Hasselblad V, Tang WHW, et al. Troponin I in acute decompensated heart failure: Insights from the ascend-hf study. Eur J Heart Fail. 2012;14:1257-1264.
7. Gattis WA, O'Connor CM, Hasselblad V, Adams KF Jr, Kobrin I, Gheorghiade M. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol. 2004;93:1436-1437.
8. O'Connor CM, Fiuzat M, Lombardi C, et al. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the protect pilot study. Circulation. 2011;4:724-732.
9. Perna ER, Macin SM, Canella JPC, et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin t monitoring for high-risk patient identification. Circulation. 2004;110:2376-2382.
10. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the united states: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
11. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
12. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006;333:597-600.
13. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. accessed July 3, 2015.
14. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-1598.
15. Peacock WF IV, De Marco T, Fonarow GC, et al.; ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117-2126.
16. Shah MR, Hasselblad V, Tasissa G, et al. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial). Am J Cardiol. 2007;100:1427-1433.
17. Le Corvoisie P, Bastuji-Garin S, Renaud B, et al. Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study. Age Ageing. 2015;44(2):225-231.
18. Perna ER, Macin SM, Cimbaro Canella JP, et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol. 2005;99:253-261.
19. Perna ER, Macin SM, Parras JI, et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J. 2002;143:814-820.
20. Parissis JT, Ikonomidis I, Rafouli-Stergiou P, et al. Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction. Am J Cardiol. 2011;107:79-84.
21. Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin t and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol. 2002;89:691-695.
22. Kuwabara Y, Sato Y, Miyamoto T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J. 2007;71:1047-1051.
23. La Vecchia L, Mezzena G, Zanolla L, et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant. 2000;19:644-652.
24. Metra M, Nodari S, Parrinello G, et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail. 2007;9:776-786.
25. Parissis JT, Papadakis J, Kadoglou NPE, et al. Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. Int J Cardiol. 2013;168:3609-3612.
26. Perna ER, Aspromonte N, Cimbaro Canella JP, et al. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study. J Card Fail. 2012;18:822-830.
27. Rudiger A, Harjola V-P, Muller A, et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail. 2005;7:662-670.
28. Wallenborn J, Stauffenberg S, Stoerk S, et al. High-sensitive troponin I after acute cardiac decompensation-distribution of baseline values and prognostic significance. Paper presented at: Heart Failure Congress 2013; May 25-28, 2013; Lisbon, Portugal.
29. Xue Y, Clopton P, Peacock WF, Maisel AS. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail. 2011;13:37-42.
30. Zairis MN, Tsiaousis GZ, Georgilas AT, et al. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol. 2010;141:284-290.
31. Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz CM, Latorre MDRDDO, Oliveira MT Jr, Ramires JAF. Cardiac troponin t for risk stratification in decompensated chronic heart failure. [in Portuguese]. Arq Bras Cardiol. 2009;92(5):404-412.
32. Guisado Espartero ME, Salamanca-Bautista P, Aramburu-Bodas O, et al. Troponin T in acute heart failure: clinical implications and prognosis in the Spanish National Registry on Heart Failure. Eur J Intern Med. 2014;25:739-744.
33. Manzano-Fernandez S, Boronat-Garcia M, Albaladejo-Oton MD, et al. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol. 2009;103:1753-1759.
34. Oliveira MDC, Alvares J, Moreira MCV. Single cardiac troponin t measurement predicts risk for adverse outcome in decompensated heart failure. Arq Bras Cardiol. 2010;94(4):495-501.
35. You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation between cardiac troponin i and mortality in acute decompensated heart failure. Am Heart J. 2007;153:462-470.
36. Nakamura Y, Yoshihisa A, Takiguchi M, et al. High-sensitivity cardiac troponin t predicts non-cardiac mortality in heart failure. Circ J. 2014;78:890-895.
37. Pascual-Figal DA, Casas T, Ordonez-Llanos J, et al. Highly sensitive troponin t for risk stratification of acutely destabilized heart failure. Am Heart J. 2012;163(6):1002-1010.
38. Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: Users' guides to the medical literature. JAMA. 2014;312:171-179.
39. Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007;116:249-257.
40. Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242-1249.
41. Biolo A, Fisch M, Balog J, et al. Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers. Circ Heart Fail. 2010;3:44-50.
42. Kop WJ, Gottdiener JS, deFilippi CR, et al. Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. Circ Heart Fail. 2012;5:406-413.
43. White HD. Pathobiology of troponin elevations: so elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57:2406-2408.
44. Nagarajan V, Hernandez AV, Tang WHW. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012;98:1778-1786.
45. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310-314.
46. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. 2001;103:2035-2037.
47. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113:1958-1965.
48. Sundstrom J, Ingelsson E, Berglund L, et al. Cardiac troponin-I and risk of heart failure: a community-based cohort study. Eur Heart J. 2009;30:773-781.
49. Gore MO, Seliger SL, Defilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin t assay. J Am Coll Cardiol. 2014;63:1441-1448.
50. McKie PM, Heublein DM, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099-1107.
51. deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494-2502.
52. Arenja N, Reichlin T, Drexler B, et al. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. J Intern Med. 2012;271:598-607.
53. Braga JR, Tu JV, Austin PC, et al. Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circulation. 2013;6:193-202.
54. Fonarow GC, Peacock WF, Horwich TB, et al.; ADHERE Scientific Advisory Committee and Investigators. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol. 2008;101:231-237.